Skip to main content

Table 3 The demographics and baseline features for relapse and non-relapse patients

From: Clinical characteristics and therapeutic response of immunoglobulin G4-related disease: a retrospective study of 127 Chinese patients

Characteristica

Total follow-up patients (n = 74)

Remission patients (n = 59)

Relapse patients (n = 15)

P value

Male gender, n (%)

54 (73.0%)

40 (67.8%)

14 (93.3%)

0.05

Age at onset (years)

60.2 (23–79)

63 (56–68)

64 (52–66)

0.3

White blood cell (109/L)

5.8 (1.0–12.2)

5.3 (4.2–7.3)

5.5 (4.7–7.3)

0.7

Eosinophils (%)

5.5 (0.07–19.6)

4.6 (2.25–7.65)

4.3 (2.7–6.5)

0.4

IgG (g/L)

2189.7 (1010.0–5590.0)

1795.0 (1570.0–2357.0)

1970 (1730–2605)

0.3

IgA (g/L)

190.0 (56.1–432.0)

187.0 (116.5–254.0)

206.5 (109.0–257.8)

0.8

IgM (g/L)

77.1 (20.1–227.0)

69.9 (43.6–101.5)

68.0 (40.1–87.0)

0.8

IgG4 (g/L)

15.6 (0.54–73.2)

10.9 (4.1–17.7)

13.2 (5.7–20.6)

0.3

IgG4-RD RI

10.0 (2–36)

8 (6–12)

8 (6–14)

0.2

Pancreato-hepato-biliary (n)

30

23

7

–b

RPF/Aorta (n)

2

2

0

–b

Head and neck-limited (n)

8

8

0

–b

Mikulicz and systemic (n)

34

26

8

–b

  1. IgG, immunoglobulin G; IgA, immunoglobulin A; IgM, immunoglobulin M; IgG4, immunoglobulin G4; IgG4-RD RI, IgG4-Related Disease Responder Index; RPF, retroperitoneal fibrosis
  2. aAll continuous variables were shown as median (Interquartile range)
  3. bBecause of smaller sample size, we did not use the Chi-square test to compare those items between two groups